4D Molecular Therapeutics Inc (FDMT) financials · rev $85.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
4D Molecular Therapeutics Inc (FDMT) rev $85.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $85.2M | $37.0K |
| Operating Income | -$159.5M | -$187.8M |
| Net Income | -$140.1M | -$160.9M |
| EPS (Diluted) | -$2.42 | -$2.98 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $566.7M | $560.4M |
| Current Assets | $413.1M | $434.9M |
| Cash & Equivalents | $60.2M | $149.3M |
| PP&E | $14.9M | $19.5M |
| Total Liabilities | $61.0M | $49.8M |
| Current Liabilities | $44.0M | $29.1M |
| Long-term Debt | N/A | N/A |
| Shareholders' Equity | $505.7M | $510.6M |
| Retained Earnings | -$716.3M | -$576.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$109.1M | -$134.6M |
| CapEx | $536.0K | $3.79M |
| Investing Cash Flow | -$93.0M | -$302.4M |
| Financing Cash Flow | $113.0M | $337.3M |
| Net Change in Cash | -$89.1M | -$99.8M |
| Free Cash Flow | -$109.6M | -$138.4M |
FAQ
What is FDMT P/E and revenue?
4D Molecular Therapeutics Inc (FDMT) rev $85.2M.
What is FDMT revenue?
4D Molecular Therapeutics Inc last cached revenue is $85.2M (FY2025).
Is FDMT profitable?
4D Molecular Therapeutics Inc last cached net income is -$140.1M (FY2025).
What are FDMT total assets?
4D Molecular Therapeutics Inc last cached total assets are $566.7M (FY2025).
What is FDMT free cash flow?
4D Molecular Therapeutics Inc last cached free cash flow is -$109.6M (FY2025).
Not investment advice. Cached statements, not a live tape.